XING Y, PU C W, SHANG K, et al. Morphological characteristics of peripheral blood cells in patients with neutral lipid storage disease with myopathy and literature review[J]. Chinese General Practice, 2022, 25 (24) : 3065-3069.
Ying XING,Chengwei PU,Ke SHANG, et al. Morphological Characteristics of Peripheral Blood Cells in Patients with Neutral Lipid Storage Disease with Myopathy and Literature Review[J]. Chinese General Practice, 2022, 25(24): 3065-3069. DOI: 10.12114/j.issn.1007-9572.2022.0185.
邢莹,普程伟,尚柯等. 中性脂肪沉积症伴肌病患者的外周血细胞形态特点并文献复习[J]. 中国全科医学, 2022, 25(24): 3065-3069. DOI: 10.12114/j.issn.1007-9572.2022.0185.
LATIMERC S,SCHLEITJ,REYNOLDSA,et al. Neutral lipid storage disease with myopathy:further phenotypic characterization of a rare PNPLA2 variant[J]. Neuromuscul Disord,2018,28(7):606-609. DOI:10.1016/j.nmd.2018.04.010.
[3]
KALYONS,GÖKDENY,DEMIRELN,et al. Chanarin-dorfman syndrome[J]. Turk J Gastroenterol,2019,30(1):105-108. DOI:10.5152/tjg.2018.18014.
[4]
夏薇,陈婷梅. 临床血液学检验技术[M]. 北京:人民卫生出版社,2015.
[5]
JORDANSG H. The familial occurrence of fat containing vacuoles in the leukocytes diagnosed in two brothers suffering from dystrophia musculorum progressiva(ERB.)[J]. Acta Med Scand,1953,145(6):419-423. DOI:10.1111/j.0954-6820.1953.tb07038.x.
[6]
ROZENSZAJNL,KLAJMANA,YAFFED,et al. Jordans'anomaly in white blood cells. Report of case[J]. Blood,1966,28(2):258-265.
[7]
LEFÈVREC,JOBARDF,CAUXF,et al. Mutations in CGI-58,the gene encoding a new protein of the esterase/lipase/thioesterase subfamily,in Chanarin-Dorfman syndrome[J]. Am J Hum Genet,2001,69(5):1002-1012. DOI:10.1086/324121.
[8]
WESSALOWSKIR,SCHROTENH,NEUEN-JACOBE,et al. Multisystem triglyceride storage disorder without ichthyosis in two siblings[J]. Acta Paediatr,1994,83(1):93-98. DOI:10.1111/j.1651-2227.1994.tb12960.x.
[9]
FISCHERJ,LEFÈVREC,MORAVAE,et al. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy[J]. Nat Genet,2007,39(1):28-30. DOI:10.1038/ng1951.
PERRINL,FÉASSONL,FURBYA,et al. PNPLA2 mutation:a paediatric case with early onset but indolent course[J]. Neuromuscul Disord,2013,23(12):986-991. DOI:10.1016/j.nmd.2013.08.008.
[13]
MISSAGLIAS,MAGGIL,MORAM,et al. Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement[J]. Neuromuscul Disord,2017,27(5):481-486. DOI:10.1016/j.nmd.2017.01.011.
[14]
KANEKOK,KURODAH,IZUMIR,et al. A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy:a case report and literature review[J]. Neuromuscul Disord,2014,24(7):634-641. DOI:10.1016/j.nmd.2014.04.001.
[15]
ZHANGW,WENB,LUJ,et al. Neutral lipid storage disease with myopathy in China:a large multicentric cohort study[J]. Orphanet J Rare Dis,2019,14(1):234. DOI:10.1186/s13023-019-1209-z.
[16]
MASSAR,POZZESSERES,RASTELLIE,et al. Neutral lipid-storage disease with myopathy and extended phenotype with novel PNPLA2 mutation[J]. Muscle Nerve,2016,53(4):644-648. DOI:10.1002/mus.24983.
[17]
PENNISIE M,MISSAGLIAS,DIMAUROS,et al. A myopathy with unusual features caused by PNPLA2 gene mutations[J]. Muscle Nerve,2015,51(4):609-613. DOI:10.1002/mus.24477.